SoftBank is making a big bet on real estate tech. The Japanese telecom giant invested $450 million in Compass, a $2.2 billion real estate company shaking up the industry. Rob Lehman, Chief Revenue Officer at Compass, was with us to discuss what the deal means for the company.
With investments ranging from Uber to WeWork, SoftBank is one of the most influential investors in the tech community. Lehman explains that his company appealed to SoftBank because they recognized a technology gap in the real estate market that Compass was filling. He also points out Compass was an attractive investment because real estate is the largest asset globally.
With the new funding, Lehman says the company will focus on growth and continued investments in technology. When it comes to emerging technologies, Compass doesn't have plans for virtual reality. Instead, the company is more focused on artificial intelligence, says Lehman. In addition to technology, the new funding will go to breaking into tier one cities such as Atlanta and Phoenix, he adds.
At its annual health event on Tuesday, Google announced a series of changes to its search tool that it said will make it easier to access information about affordable health care services.
The Environmental Protection Agency (EPA) is proposing the nation's first-ever drinking water standard around polyfluoroalkyl substances (PFAS) or "forever chemicals."
It's Women's History Month and Tuesday marks Equal Pay Day. To honor the occasion, Laura Gassner Otting, author of Limitless: How to Ignore Everybody, Carve Your Own Path, and Live Your Best Life, spoke with Cheddar News' correspondent Shannon LaNier about how to properly value yourself and get the pay you deserve, regardless of your gender.
Southwest Airlines Co. on Tuesday outlined a plan to strengthen its operational resilience after a winter storm late last year led to widespread cancellations and delays.
Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up 75 percent for people living with diabetes starting in January 2024.